US Pricing Squeeze Clouds Sun Pharma Q2; Site Re-Inspection Critical

 
• By Anju Ghangurde
  
MT1607_moneybox_1200x675
SUN REPORTED A TOUGH Q2 BUT EXPECTS A GRADUAL IMPROVEMENT IN THE SECOND HALF
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business